AN OBSERVATIONAL STUDY ON MEDICATION ADHERENCE AND PREVALENCE OF COMPLICATIONS IN TYPE 2 DIABETES MELLITUS PATIENTS

  • GEETHA RANI VALAPARLA Department of Pharmacology, A. M. Reddy Memorial College of Pharmacy, Petlurivaripalem, Nararaopet, Guntur, Andhra Pradesh, India
  • PRANEETHA MADDI Department of Pharmacology, A. M. Reddy Memorial College of Pharmacy, Petlurivaripalem, Nararaopet, Guntur, Andhra Pradesh, India
  • KALYAN BABU VAKA Department of Pharmacology, A. M. Reddy Memorial College of Pharmacy, Petlurivaripalem, Nararaopet, Guntur, Andhra Pradesh, India

Abstract

Objective: Diabetes is a complex heterogeneous disorder with chronic multiple illness which needs continuous medical management. Along with the medication life style modifications (diet, exercise) and patient self-management education is necessary not only for glyceamic control but also for prevention and delay of acute and long term complications. In this regard an observational study was carried out among 167 type 2 diabetic patients using a self-administered questionnaire in tertiary care hospital, Guntur.


Methods: Patients of both genders in the age of 30-89 with co morbidities were included in the study. Data regarding social habits, medication and adherence, duration of diabetes, co-morbidities, presence of diabetic complications along with the prevalence of complications while practicing regular diet, exercise with medical adherence was collected and evaluated.


Results: Among 167 patients 64.64 % were male and 35.36% were female. 14.4% of the populations are with diabetes from more than 17years. 65.3% of the patients don’t have alcoholic and smoking habit. Only 51.5% of the population was adherent to the medications. Hypertension is major co-morbidity existing among them. 82% of the study population reported macro vascular complication. The periodic prevalence rate(1-5years) of complications in type 2 diabetic patients who are adherent to medications and life style modifications was found to be 11.4% and the periodic prevalence rate of complications in patients who are either non-adherent to medications or life style modifications was 88.6%.


Conclusion: Medical and life style adherence is strongly recommended which also must be promoted by conducting awareness programme and health care camps with continuous supervision by the family members over patients for healthy society.

Keywords: Diabetic complications, Life style modifications, Medication adherence, Type 2 diabetes mellitus

References

1. Latha S, Vijaya Kumar R. The facts about diabetes mellitus-a review. Galore Int J Health Sci Res 2019;4:64-75.
2. Akram TK, Hisham MD. Diabetes mellitus: the epidemic of the century. World J Diabetes 2015;6: 850–67.
3. Pouya S, Inga P, Paraskevi S. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. 9th edition. Diabetes Res Clin Pract 2019;157:107843.
4. Mohammed MMAHM, Phung H, Jing S, Donald EM. Improving adherence to in adults with diabetes in the united arab emirates. BMC Public Health 2016;16:1-11.
5. William HP, Robert RH. Poor medication adherence in type 2 diabetes: recognising the scope of problem and its key contributors. Patient Performance Adherence 2016;10:1299-307.
6. American diabetes association. Improving care and promoting health in population: standards of medical care in diabetes. Diabetes Care 2019;42(Suppl 1):s7-s12.
7. Kindig D, Stoddart G. What is population health? Am J Public Health 2003;93:380–3.
8. Bonett DG. Sample size requirements for testing and estimating coefficient alpha. J Edu Behav Statistics 2002;27:335-40.
9. Mohamad AB, Evi DO, Nur AB. A review on sample size determination for cronbach’s alpha test: a simple guide for researchers. Malaysian J Med Sci 2018;25:85-99.
Statistics
25 Views | 31 Downloads
Citations
How to Cite
VALAPARLA, G. R., P. MADDI, and K. B. VAKA. “AN OBSERVATIONAL STUDY ON MEDICATION ADHERENCE AND PREVALENCE OF COMPLICATIONS IN TYPE 2 DIABETES MELLITUS PATIENTS”. International Journal of Current Pharmaceutical Research, Vol. 13, no. 2, Mar. 2021, pp. 64-66, doi:10.22159/ijcpr.2021v13i2.41560.
Section
Original Article(s)